IKT earnings: a positive outcome, +5.9%

On October 16, 2023, Inhibikase Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.9% in the window around the event. It had already run -42.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.